← back to search

Emiko Sato

Tohoku University · JP
Area of research
Obstetrics and Gynecology · Nephrology
Research interest
Research interests include Pregnancy and preeclampsia studies, Dialysis and Renal Disease Management, Birth, Development, and Health, and Blood Coagulation and Thrombosis Mechanisms.
h-index
34
citations
5,217
works
254
NIH funding
primary concept
Medicine
email

Recent publications

Generation of thiyl radicals in a spatiotemporal controlled manner by light: Applied for the cis to trans isomerization of unsaturated fatty acids/phospholipids.
2025cited by 4position: contributordoi
Hemodialysis employing molecular hydrogen (H<sub>2</sub>) enriched dialysis solution may improve dialysis related fatigue through impact on energy metabolism.
2025cited by 2position: contributordoi
Nicotinamide ameliorates podocyte injury and albuminuria in adriamycin-induced nephropathy.
2025cited by 1position: contributordoi
Lactoferrin attenuates renal fibrosis and uremic sarcopenia in a mouse model of adenine-induced chronic kidney disease.
2025cited by 0position: contributordoi
Elaidic acid drives cellular senescence and inflammation via lipid raft-mediated IL-1R signaling.
2025cited by 0position: contributordoi
Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria.
2024cited by 16position: contributordoi
Industrially produced trans-fatty acids are potent promoters of DNA damage-induced apoptosis.
2024cited by 5position: contributordoi
Impacts of low birthweight on kidney development and intergenerational growth of the offspring.
2024cited by 2position: contributordoi
A comprehensive toxicological analysis of trans-fatty acids (TFAs) reveals a pro-apoptotic action specific to industrial TFAs counteracted by polyunsaturated FAs.
2023cited by 7position: contributordoi
Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study.
2023cited by 1position: contributordoi
A non-canonical vitamin K cycle is a potent ferroptosis suppressor
Nature 2022cited by 663position: middledoi
A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
2022cited by 533position: contributordoi
What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
2022cited by 54position: contributordoi
Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells.
2022cited by 19position: contributordoi
A comprehensive toxicological analysis of trans-fatty acids (TFAs): the pro-apoptotic action of industrial TFAs is counteracted by polyunsaturated fatty acids
2022cited by 0position: contributordoi
Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease.
2021cited by 39position: contributordoi
Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease.
2021cited by 27position: contributordoi
Lack of Endothelial Nitric Oxide Synthase Accelerates Ectopic Calcification in Uremic Mice Fed an Adenine and High Phosphorus Diet.
2021cited by 17position: contributordoi
Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet.
2021cited by 6position: contributordoi
Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.
2020cited by 143position: contributordoi
Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition.
2020cited by 22position: contributordoi
Metabolomics of a mouse model of preeclampsia induced by overexpressing soluble fms-like tyrosine kinase 1.
2020cited by 22position: contributordoi
Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice.
2020cited by 22position: contributordoi
Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
2020cited by 18position: contributordoi
Protease-activated receptor 2 contributes to placental development and fetal growth in mice.
2020cited by 5position: contributordoi
Uremic toxins alter coagulation and fibrinolysis-related genes expression in human endothelial cells.
2020cited by 4position: contributordoi
The effect of aldosterone on adiposity - The role of glucose absorption in the small intestine.
2020cited by 2position: contributordoi
Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity.
2019cited by 19position: contributordoi
Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
2019cited by 19position: contributordoi
Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats.
2019cited by 15position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Eikan Mishima · Tohoku University4 papers (2020–2023)Sadayoshi Ito · Tohoku University3 papers (2012–2020)Takaaki Abe · Tohoku Institute of Technology2 papers (2020–2022)Yoshiro Saito · University of Antwerp2 papers (2024–2025) · 2 papers (2020–2022) · 2 papers (2020–2020) · 2 papers (2020–2022) · 1 papers (2012–2012)Christopher J. Chang · Princeton University1 papers (2012–2012)Chunyan Hu · National Health and Family Planning Commission1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012)Qi Guo · Shanghai University of Traditional Chinese Medicine1 papers (2012–2012)Ken‐ichi Yamada · Kyushu University1 papers (2022–2022)Takefumi Mori · Medical College of Wisconsin1 papers (2012–2012)Yi Lu · Nantong University1 papers (2012–2012)Yusuke Ohsaki · Medical College of Wisconsin1 papers (2012–2012)Takuya Noguchi · Tohoku University1 papers (2024–2024) · 1 papers (2022–2022)